{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:52:53Z","timestamp":1791251573424,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.antiviral.2013.05.012","type":"journal-article","created":{"date-parts":[[2013,6,2]],"date-time":"2013-06-02T12:31:39Z","timestamp":1370176299000},"page":"172-179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Inhibition of multiplication of the prototypic arenavirus LCMV by valproic acid"],"prefix":"10.1016","volume":"99","author":[{"given":"\u00c1ngela","family":"V\u00e1zquez-Calvo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A.","family":"Mart\u00edn-Acebes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan-Carlos","family":"S\u00e1iz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nhi","family":"Ngo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Sobrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"de la Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2013.05.012_b0005","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1067\/mob.2002.126297","article-title":"Lymphocytic choriomeningitis virus: emerging fetal teratogen","volume":"187","author":"Barton","year":"2002","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.antiviral.2013.05.012_b0010","first-page":"6","article-title":"Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24 well plates","volume":"10","author":"Battegay","year":"1993","journal-title":"ALTEX"},{"key":"10.1016\/j.antiviral.2013.05.012_b0015","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1001\/jama.287.18.2391","article-title":"Hemorrhagic fever viruses as biological weapons: medical and public health management","volume":"287","author":"Borio","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.antiviral.2013.05.012_b0020","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1001\/archneur.1979.00500430023002","article-title":"Valproic acid. Review of a new antiepileptic drug","volume":"36","author":"Bruni","year":"1979","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.antiviral.2013.05.012_b0195","series-title":"Arenaviridae: The Viruses and Their Replication","volume":"vol. 2","author":"Buchmeier","year":"2007"},{"key":"10.1016\/j.antiviral.2013.05.012_b0030","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0042-6822(81)90137-9","article-title":"Monoclonal antibodies to lymphocytic choriomeningitis and pichinde viruses: generation, characterization, and cross-reactivity with other arenaviruses","volume":"113","author":"Buchmeier","year":"1981","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2013.05.012_b0035","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.virol.2008.09.008","article-title":"A cell-based luciferase assay amenable to high-throughput screening of inhibitors of arenavirus budding","volume":"382","author":"Capul","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2013.05.012_b0040","doi-asserted-by":"crossref","first-page":"9415","DOI":"10.1128\/JVI.75.19.9415-9426.2001","article-title":"RING finger Z protein of lymphocytic choriomeningitis virus (LCMV) inhibits transcription and RNA replication of an LCMV S-segment minigenome","volume":"75","author":"Cornu","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.05.012_b0045","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/00007691-198612000-00005","article-title":"Variable free and total valproic acid concentrations in sole- and multi-drug therapy","volume":"8","author":"Cramer","year":"1986","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.antiviral.2013.05.012_b0050","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1073\/pnas.0900088106","article-title":"Generation of recombinant lymphocytic choriomeningitis viruses with trisegmented genomes stably expressing two additional genes of interest","volume":"106","author":"Emonet","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.antiviral.2013.05.012_b0055","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1038\/nm1142","article-title":"Exotic emerging viral diseases: progress and challenges","volume":"10","author":"Geisbert","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2013.05.012_b0060","first-page":"486","article-title":"Lymphocytic choriomeningitis virus. A neglected pathogen of man","volume":"116","author":"Jahrling","year":"1992","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.antiviral.2013.05.012_b0065","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1046\/j.1535-7597.2003.03314.x","article-title":"The pharmacology of parenteral valproate","volume":"3","author":"Kanner","year":"2003","journal-title":"Epilepsy Curr."},{"key":"10.1016\/j.antiviral.2013.05.012_b0070","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.virol.2009.02.042","article-title":"Receptor binding and cell entry of Old World arenaviruses reveal novel aspects of virus\u2013host interaction","volume":"387","author":"Kunz","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2013.05.012_b0075","first-page":"111","article-title":"Receptor structure, binding, and cell entry of arenaviruses","volume":"262","author":"Kunz","year":"2002","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.antiviral.2013.05.012_b0080","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1128\/JVI.74.8.3470-3477.2000","article-title":"NP and L proteins of lymphocytic choriomeningitis virus (LCMV) are sufficient for efficient transcription and replication of LCMV genomic RNA analogs","volume":"74","author":"Lee","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.05.012_b0085","doi-asserted-by":"crossref","first-page":"6393","DOI":"10.1128\/JVI.76.12.6393-6397.2002","article-title":"Identification of the lymphocytic choriomeningitis virus (LCMV) proteins required to rescue LCMV RNA analogs into LCMV-like particles","volume":"76","author":"Lee","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.05.012_b0090","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.antiviral.2005.02.007","article-title":"Identification of natural compounds with antiviral activities against SARS-associated coronavirus","volume":"67","author":"Li","year":"2005","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.05.012_b0095","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1099\/vir.0.017053-0","article-title":"An interfering activity against lymphocytic choriomeningitis virus replication associated with enhanced mutagenesis","volume":"91","author":"Martin","year":"2010","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2013.05.012_b0100","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0002-9394(00)00570-5","article-title":"Lymphocytic choriomeningitis virus: an underdiagnosed cause of congenital chorioretinitis","volume":"130","author":"Mets","year":"2000","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.antiviral.2013.05.012_b0105","doi-asserted-by":"crossref","first-page":"12978","DOI":"10.1073\/pnas.2133782100","article-title":"The small RING finger protein Z drives arenavirus budding: implications for antiviral strategies","volume":"100","author":"P\u00e9rez","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.antiviral.2013.05.012_b0110","doi-asserted-by":"crossref","first-page":"11443","DOI":"10.1128\/JVI.78.20.11443-11448.2004","article-title":"Myristoylation of the RING finger Z protein is essential for arenavirus budding","volume":"78","author":"Perez","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.05.012_b0115","first-page":"65","article-title":"Human infection with arenaviruses in the Americas","volume":"262","author":"Peters","year":"2002","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.antiviral.2013.05.012_b0120","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1128\/JVI.02229-10","article-title":"Use of single-cycle infectious lymphocytic choriomeningitis virus to study hemorrhagic fever arenaviruses","volume":"85","author":"Rodrigo","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.05.012_b0125","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.biopsych.2004.08.027","article-title":"Valproate decreases inositol biosynthesis","volume":"56","author":"Shaltiel","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.antiviral.2013.05.012_b0130","first-page":"432","article-title":"Ribavirin therapy for lassa fever","volume":"232","author":"Snell","year":"1988","journal-title":"Practitioner"},{"key":"10.1016\/j.antiviral.2013.05.012_b0135","doi-asserted-by":"crossref","first-page":"10700","DOI":"10.1128\/JVI.77.19.10700-10705.2003","article-title":"Lassa virus Z protein is a matrix protein and sufficient for the release of virus-like particles","volume":"77","author":"Strecker","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.05.012_b0140","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1042\/BST0371126","article-title":"Structure\u2013function studies for the panacea, valproic acid","volume":"37","author":"Terbach","year":"2009","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.antiviral.2013.05.012_b0145","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1091\/mbc.E07-09-0982","article-title":"The mood stabilizer valproate inhibits both inositol- and diacylglycerol-signaling pathways in Caenorhabditis elegans","volume":"19","author":"Tokuoka","year":"2008","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.antiviral.2013.05.012_b0150","doi-asserted-by":"crossref","first-page":"4578","DOI":"10.1128\/JVI.06604-11","article-title":"The PI3K\/Akt pathway contributes to arenavirus budding","volume":"86","author":"Urata","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.05.012_b0155","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1128\/JVI.80.8.4191-4195.2006","article-title":"Cellular factors required for Lassa virus budding","volume":"80","author":"Urata","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.05.012_b0160","doi-asserted-by":"crossref","first-page":"12651","DOI":"10.1128\/JVI.01012-09","article-title":"The z protein of the new world arenavirus tacaribe virus has bona fide budding activity that does not depend on known late domain motifs","volume":"83","author":"Urata","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.05.012_b0165","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1128\/JVI.01717-10","article-title":"Inhibition of enveloped virus infection of cultured cells by valproic acid","volume":"85","author":"Vazquez-Calvo","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.05.012_b0170","doi-asserted-by":"crossref","first-page":"10678","DOI":"10.1074\/jbc.M109.057836","article-title":"Histone deacetylase inhibitor valproic acid inhibits cancer cell proliferation via down-regulation of the alzheimer amyloid precursor protein","volume":"285","author":"Venkataramani","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2013.05.012_b0175","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/0042-6822(88)90616-2","article-title":"Fine mapping of a peptide sequence containing an antigenic site conserved among arenaviruses","volume":"164","author":"Weber","year":"1988","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2013.05.012_b0205","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00280-010-1287-z","article-title":"The histone deacetylase inhibitor valproic acid sensitizes human and canine osteosarcoma to doxorubicin","volume":"67","author":"Wittenburg","year":"2011","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.antiviral.2013.05.012_b0185","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1073\/pnas.0909587107","article-title":"A broad-spectrum antiviral targeting entry of enveloped viruses","volume":"107","author":"Wolf","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.antiviral.2013.05.012_b0190","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1128\/EC.00104-06","article-title":"Attenuation of phospholipid signaling provides a novel mechanism for the action of valproic acid","volume":"6","author":"Xu","year":"2007","journal-title":"Eukaryot. Cell"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354213001435?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354213001435?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T15:23:24Z","timestamp":1539617004000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354213001435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0166354213001435"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2013.05.012","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of multiplication of the prototypic arenavirus LCMV by valproic acid","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2013.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}